Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Millennium Management LLC

Millennium Management LLC decreased its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 78.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,893 shares of the company's stock after selling 32,385 shares during the quarter. Millennium Management LLC's holdings in Prestige Consumer Healthcare were worth $694,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Franklin Resources Inc. raised its position in shares of Prestige Consumer Healthcare by 0.7% during the fourth quarter. Franklin Resources Inc. now owns 21,735 shares of the company's stock worth $1,697,000 after purchasing an additional 150 shares during the period. CIBC Private Wealth Group LLC raised its holdings in Prestige Consumer Healthcare by 48.9% in the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after acquiring an additional 152 shares in the last quarter. QRG Capital Management Inc. raised its holdings in Prestige Consumer Healthcare by 3.3% in the 4th quarter. QRG Capital Management Inc. now owns 5,496 shares of the company's stock valued at $429,000 after acquiring an additional 176 shares in the last quarter. O Shaughnessy Asset Management LLC raised its holdings in shares of Prestige Consumer Healthcare by 3.0% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 7,026 shares of the company's stock worth $549,000 after buying an additional 207 shares in the last quarter. Finally, Summit Investment Advisors Inc. increased its stake in shares of Prestige Consumer Healthcare by 4.2% in the fourth quarter. Summit Investment Advisors Inc. now owns 5,182 shares of the company's stock valued at $405,000 after buying an additional 211 shares in the last quarter. Institutional investors and hedge funds own 99.95% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on PBH. Oppenheimer lifted their price objective on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a research note on Thursday, February 13th. Royal Bank of Canada raised Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Finally, Wall Street Zen upgraded Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, May 17th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Trading Down 1.7%

PBH stock traded down $1.51 during trading on Wednesday, reaching $85.13. The company had a trading volume of 302,080 shares, compared to its average volume of 299,446. Prestige Consumer Healthcare Inc. has a 52 week low of $63.79 and a 52 week high of $90.04. The company has a market cap of $4.21 billion, a P/E ratio of 19.94, a PEG ratio of 2.69 and a beta of 0.45. The business has a 50 day moving average of $83.61 and a 200 day moving average of $82.56. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.02. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. The company had revenue of $296.52 million for the quarter, compared to analysts' expectations of $289.36 million. During the same quarter last year, the company posted $1.02 earnings per share. The firm's quarterly revenue was up 7.0% on a year-over-year basis. As a group, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.